🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Dogma-challenging 🇦🇺RCT in roypounder.apt : No harmful effect in active CD of #diet enriched by 3 emulsifiers (incriminated by pre-clinucal data). Small trial, but sits well with benefits of EEN, despite high emulsifier content of formulas. Search goes on... onlinelibrary.wiley.com/doi/10.1111/ap…

A nested case-control study within large population-based cohorts examines preclinical protein signatures of #CrohnsDisease and #UlcerativeColitis. Read the article here: ow.ly/Vtqp50VrGG7

What if a molecule produced by gut microbes can boost the effectiveness of a novel treatment for #Crohnsdisease❓ ✅ Of 85 Crohn’s disease patients receiving ustekinumab, about half achieved clinical remission after 52 weeks ✅ Patients in remission showed: 🔸distinct

Intestinal Epithelial Serotonin as a Novel Target for Treating Disorders of Gut-Brain Interaction and Mood - Gastroenterology gastrojournal.org/article/S0016-…

Bifidobacteria support optimal infant vaccine responses ⁦nature⁩ nature.com/articles/s4158…

In #Microbiome 🔍Using a piglet model to examine the potential role of Faecalibacterium prausnitzii in PEDV infections🐖 💡F.prausnitzii significantly reduced viral load & mitigated disease progression during viral infection 👉doi.org/pf3b

New link between the gut Microbiome, bile acids and Osteoarthritis : Osteoarthritis treatment via the GLP-1–mediated gut-joint axis targets intestinal FXR signaling | Science science.org/doi/10.1126/sc…

📭 From CMGH, check out this article! 📰 Genetic and Microbial Analysis of Invasiveness for Escherichia coli Strains Associated With Inflammatory Bowel Disease 👨‍⚕️ Kevin Forsberg 🔗 ow.ly/pgHy50VwqIG

Appendicectomy plus standard medical therapy versus standard medical therapy alone for maintenance of remission in ulcerative colitis (ACCURE): a pragmatic, open-label, international, randomised trial - The Lancet Gastroenterology & Hepatology thelancet.com/journals/langa…

Dr. Harry Sokol, an expert in gut microbiota and IBD, will present a seminar on “Gut Microbiome in IBD: From Description to Therapeutic Intervention”. events.ucalgary.ca/snyder/event/4… #GutMicrobiome #IBD #SnyderInstitute #MedicalResearch #SeminarSeries #MicrobiomeScience #FreeEvent

Global evolution of inflammatory bowel disease across epidemiologic stages | ⁦nature⁩ ⁦⁦Gil Kaplan MD MPH⁩ nature.com/articles/s4158…

Microbial metabolite drives ageing-related clonal haematopoiesis via ALPK1 | ⁦nature⁩ nature.com/articles/s4158…

The future of #IBD therapy is #MICROBIOME Harry Sokol #ACG2025

Is the gut microbiota an actor in IBD pathogenesis? YES, and translation to the clinic is on the way Complete masterclass by Harry Sokol #DDW2025 Modify gut microbiota impacts disease severity • In mice models • In humans (FMT) Faecal microbiota from patients with IBD

The gut microbiome has a lot to say in #IBD Harry Sokol updates tryptophan, aryl-hydrocarbons and the microbiome potential role on IBD pathways #DDW2025 Digestive Disease Week

What an absolute honour and privilege to host Prof. Harry Sokol Harry Sokol at the University of Calgary as part of the Snyder Institute for Chronic Diseases endowed chair series . A packed auditorium listening to a masterful talk on the gut microbiota and IBD. Harry is trailblazing the field .

👋🏻Hi Paris! Day 1 of the 3rd GlycanTrigger GA meeting. We started with a warm welcome from our coordinator, Prof Salome Pinho and our host partner Dr. Harry Sokol (Sorbonne Université), followed by a seminar delivered by Prof. Guy Gorochov on “Gut Microbiota and IgA”. Stay tuned!👀

Wrapping up day 1 of our 3rd GlycanTrigger GA meeting 🗼A productive day of presentations and discussions. Through project updates, expert talks, and dialogue, we're continuing to push forward our mission to unravel the role of the gut glycome in immune-mediated diseases💡

Thank you so much Harry Sokol for the organisation of these 2 amazing days of GlycanTrigger meeting full of great science and exciting ongoing results 🧫🧪hosted in the charming city of Paris 🇫🇷 #glycotime i3S-Instituto de Investigação e Inovação em Saúde

Happy to share our Perspective "Microbiome for clinicians" authors.elsevier.com/sd/article/S00…, just out in Cell. A piece written by #microbiomeclinicians (Siew Ng Giovanni Cammarota Harry Sokol Eran Elinav ElinavLab WeersmaLab & many others) for #microbiome clinicians.